Q4 2013

Source filing unavailable

Q4 2013 · —

derived · Computed from the longer spans the company filed.

Revenue—

Net income—

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Cash Flowderived-$539,803—

Free Cash Flowderived-$539,803—

Same quarter

no prior Q4 2012 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Biomolecular Life Holdings, Inc. · CIK 1091326 · Engraved from SEC EDGAR